Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer
- PMID: 27855989
- DOI: 10.1016/j.ygyno.2016.11.011
Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer
Abstract
Objective: Concurrent chemoradiotherapy is usually administered to patients with locally advanced cervical cancer (LACC). Extended-field chemoradiotherapy is required if para-aortic lymph node (PALN) metastasis is detected. This study aimed to construct a prediction model for PALN metastasis in patients with LACC before definitive treatment.
Methods: Between 2009 and 2016, all consecutive patients with LACC who underwent para-aortic lymphadenectomy at two tertiary centers were retrospectively analyzed. A multivariate logistic model was constructed, from which a prediction model for PALN metastasis was developed and internally validated. Before analysis, risk grouping was predefined based on the likelihood ratio.
Results: In total, 245 patients satisfied the eligibility criteria. Thirty-four patients (13.9%) had pathologically proven PALN metastases. Additionally, 16/222 (7.2%) patients with negative PALNs on positron emission tomography/computed tomography (PET/CT) had PALN metastasis. Moreover, 11/105 (10.5%) patients with both negative PALNs and positive pelvic lymph nodes on PET/CT had PALN metastasis. Tumor size on magnetic resonance imaging and PALN status on PET/CT were independent predictors of PALN metastasis. The model incorporating these two predictors displayed good discrimination and calibration (bootstrap-corrected concordance index=0.886; 95% confidence interval=0.825-0.947). The model categorized 169 (69%), 52 (22%), and 23 (9%) patients into low-, intermediate-, and high-risk groups, respectively. The predicted probabilities of PALN metastasis for these groups were 2.9, 20.8, and 76.2%, respectively.
Conclusion: We constructed a robust model predicting PALN metastasis in patients with LACC that may improve clinical trial design and help clinicians determine whether nodal-staging surgery should be performed.
Keywords: Cervical cancer; Likelihood functions; Lymph node excision; Lymphatic metastasis; Morbidity.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Added value of para-aortic surgical staging compared to 18F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study.Eur J Surg Oncol. 2020 May;46(5):883-887. doi: 10.1016/j.ejso.2019.11.496. Epub 2019 Nov 11. Eur J Surg Oncol. 2020. PMID: 31784203
-
Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?J Robot Surg. 2018 Mar;12(1):49-58. doi: 10.1007/s11701-017-0685-1. Epub 2017 Mar 2. J Robot Surg. 2018. PMID: 28255734
-
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.Ann Surg Oncol. 2011 Aug;18(8):2302-9. doi: 10.1245/s10434-011-1583-9. Epub 2011 Feb 23. Ann Surg Oncol. 2011. PMID: 21347790
-
Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.Gynecol Oncol. 2022 Mar;164(3):667-674. doi: 10.1016/j.ygyno.2021.12.026. Epub 2021 Dec 27. Gynecol Oncol. 2022. PMID: 34969533 Review.
-
Pretreatment retroperitoneal para-aortic lymph node staging in advanced cervical cancer: a review.Int J Gynecol Cancer. 2014 Jul;24(6):973-83. doi: 10.1097/IGC.0000000000000177. Int J Gynecol Cancer. 2014. PMID: 24978708 Review.
Cited by
-
Evaluation of the toxicity of prophylactic extended-field radiation therapy with volumetric modulated arc therapy in combination with concomitant chemoradiotherapy in patients with locally advanced stage IIIC1r cervical cancer according to the 2018 FIGO classification.Rep Pract Oncol Radiother. 2024 Mar 18;29(1):42-50. doi: 10.5603/rpor.99353. eCollection 2024. Rep Pract Oncol Radiother. 2024. PMID: 39165598 Free PMC article.
-
Promising predictive molecular biomarkers for cervical cancer (Review).Int J Mol Med. 2024 Jun;53(6):50. doi: 10.3892/ijmm.2024.5374. Epub 2024 Apr 12. Int J Mol Med. 2024. PMID: 38606495 Free PMC article. Review.
-
Controversies in the Staging of Patients with Locally Advanced Cervical Cancer.Diagnostics (Basel). 2023 May 16;13(10):1747. doi: 10.3390/diagnostics13101747. Diagnostics (Basel). 2023. PMID: 37238231 Free PMC article. Review.
-
The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysis.Clin Transl Radiat Oncol. 2022 May 30;35:97-103. doi: 10.1016/j.ctro.2022.05.006. eCollection 2022 Jul. Clin Transl Radiat Oncol. 2022. PMID: 35669003 Free PMC article. Review.
-
Cost-Effectiveness Analysis of Diagnostic Tests for Para-Aortic Lymph Node Detection in Locally Advanced Cervical Cancer.Clinicoecon Outcomes Res. 2021 Nov 22;13:943-955. doi: 10.2147/CEOR.S327698. eCollection 2021. Clinicoecon Outcomes Res. 2021. PMID: 34848981 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical